Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-072060
Filing Date
2022-11-14
Accepted
2022-11-14 14:54:39
Documents
38
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_jowayhealth.htm   iXBRL 10-Q 244845
2 CERTIFICATION f10q0922ex31-1_jowayhealth.htm EX-31.1 9944
3 CERTIFICATION f10q0922ex32-1_jowayhealth.htm EX-32.1 4110
  Complete submission text file 0001213900-22-072060.txt   1606966

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gtvi-20220930.xsd EX-101.SCH 25735
5 XBRL CALCULATION FILE gtvi-20220930_cal.xml EX-101.CAL 14909
6 XBRL DEFINITION FILE gtvi-20220930_def.xml EX-101.DEF 80200
7 XBRL LABEL FILE gtvi-20220930_lab.xml EX-101.LAB 190573
8 XBRL PRESENTATION FILE gtvi-20220930_pre.xml EX-101.PRE 86501
32 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_jowayhealth_htm.xml XML 105325
Mailing Address NO 19 BAOWANG ROAD BAODI ECONOMIC DEVELOPMENT ZONE TIANJIN, PRC F4 300180
Business Address NO 19 BAOWANG ROAD BAODI ECONOMIC DEVELOPMENT ZONE TIANJIN, PRC F4 300180 862258896888
Joway Health Industries Group Inc (Filer) CIK: 0001263364 (see all company filings)

EIN.: 980221494 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-108715 | Film No.: 221384067
SIC: 6770 Blank Checks